On July 16, 2026, Geoffrey Gates Scott, a board member at Aehr Test Systems, concluded the sale of 30,000 shares in the company. The average price of each share was $82.13, generating a total of around $2.5 million from the deal. The SEC Form 4 filing disclosed that his spouse sold 20,000 of these shares, while 10,000 were donated to the Scott Family Fund, a charitable trust.
As of the end of trading on July 16, the value of Aehr Test Systems shares rose to $84.20 each. A few weeks later, on August 4, the stock further climbed past $100 per share, continuing its upward movement. Over the past year, the stock had already appreciated significantly in value.
Recent Stock Performance and Company Momentum
The recent stock sale followed an impressive 469.69% increase in Aehr Test Systems’ share price over the last twelve months. Much of this growth is linked to the company's strong fourth-quarter performance, which concluded on May 29. During that period, Aehr Test Systems reported revenue of $18.8 million. This marked a considerable rise compared to the $14.1 million reported in the same time frame the previous year. The increased demand from semiconductor firms, especially those involved in artificial intelligence development, has driven much of this growth.
Aehr Test Systems is a central player in the semiconductor testing industry, providing burn-in and testing solutions for a variety of integrated circuits. The company has built a market capitalization of $2.5 billion and achieved trailing twelve-month revenues of $50.9 million.
Although the recent transaction did not affect Geoffrey Scott’s personal stockholdings directly, it did result in a 40% reduction in the combined stake held with his spouse. After the sale, Scott still retained ownership of approximately 115,000 shares, including 54,522 shares he owns outright and 60,686 shares he and his spouse collectively own via a trust.
In addition to his current stock holdings, Scott also owns unvested restricted stock units. These units cannot be sold until they fully vest, which keeps the director's financial interests aligned with those of the company’s shareholders. Despite the recent reduction in stock, Scott's remaining holdings demonstrate continued confidence in the company's long-term prospects and direction. The company's recent success reflects strong demand for its specialized products and aligns with ongoing advancements in technology. For investors contemplating whether to purchase Aehr Test Systems shares, the company’s performance and market position still present compelling opportunities.
Founded in 1977 and based in Fremont, California, Aehr Test Systems designs and produces burn-in and test systems for various integrated circuits, such as logic, optical, and memory devices. Its primary offerings include the ABTS and FOX-P families of test and burn-in solutions, serving as an essential part of the semiconductor manufacturing and validation process.
The company earns revenue by selling specialized semiconductor testing equipment and complementary components, such as WaferPak aligners, contactors, and carriers.
With 136 employees and a focus on niche, capital-intensive operations, Aehr Test Systems plays a critical role in the validation stage of semiconductor production. The company’s strategic positioning in the semiconductor ecosystem, combined with the rise in artificial intelligence and technology adoption, has contributed to its growth and success.